Rate My Professor Danny Huang

Huang's research investigates the ubiquitin-proteasome system, focusing on post-translational modifications by ubiquitin and ubiquitin-like proteins that govern critical cellular functions such as cell cycle progression, transcription, DNA repair, and virus budding. Dysregulation of these pathways contributes to cancer, neurodegenerative diseases, and viral infections. His laboratory employs X-ray crystallography and biochemical techniques to dissect the regulatory mechanisms and catalytic functions of RING E3 ubiquitin ligases, comprising approximately 600 members in humans. Notable achievements include elucidating the basis for a ubiquitin-like protein thioester switch (Nature, 2007), E2-RING expansion in the NEDD8 cascade (Molecular Cell, 2009), structural basis for c-Cbl autoinhibition and activation (Nature Structural & Molecular Biology, 2012), mechanism of ubiquitin transfer by BIRC7 RING dimer (Nature Structural & Molecular Biology, 2012), activation by non-covalent ubiquitin (Molecular Cell, 2015), and separating MDM2 degradation from p53 regulation (Nature Structural & Molecular Biology, 2017). Recent publications address tuning ubiquitin transfer by RING E3s (Life Science Alliance, 2025), DTX3L ubiquitination of single-stranded nucleic acids (eLife, 2024), and engineered ubiquitin binding peptides (Chemical Science, 2024). In 2006, he was awarded the Lorne Protein Young Investigator Award. His structural studies have paved the way for E1 inhibitors now in clinical trials and novel PROTAC-based therapies, demonstrating reduced toxicity in MDM2-p53 targeting.